Bβ15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion*

Authors:

Abstract
The fibrin-derived peptide Bβ15-42 (also called FX06) has been shown to reduce myocardial infarct size following ischemia/reperfusion. Hemorrhagic shock (HS) followed by volume resuscitation represents a similar scenario, whereby a whole organism is vulnerable to reperfusion injury. We subjected male farm-bred landrace pigs (∼30 kg) to HS by withdrawing blood to a mean arterial pressure of 40 mm Hg for 60 minutes. Pigs were then resuscitated with shed blood and crystalloids for 60 minutes, and at this time, FX06 (2.4 mg/kg, n = 8) or vehicle control (phosphate buffered saline; 2.4 mg/kg, n = 7) was injected as an intravenous bolus. University hospital laboratory. Anesthetized male farm-bred landrace pigs. Data are presented as mean ± sd. Five hours after resuscitation, controls presented acute lung injury (Pao2/Fio2-ratio *400 mm Hg; extra-vascular lung water index: *5.2 ± 2.1 mL/kg, cardiac index: *6.3 ± 1.4 L/min/m2; stroke volume index: *51 ± 11 mL/m2; cardiac TnT levels: *0.11 ± 0.09 ng/mL; *p < 0.05). Also, tissue oxygenation (tpO2; mm Hg) was significantly improved during reperfusion in FX06-treated pigs when compared with controls (liver 51 ± 4 vs. *65 ± 4; serosa 44 ± 5 vs. *55 ± 7; mucosa 14 ± 4 vs. *26 ± 4). Finally, FX06 reduced accumulation of myeloperoxidase-positive cells (mainly neutrophils) in myocardium, liver, and small intestine and reduced interleukin-6 plasma levels (*p < 0.05; compared with controls). We conclude that in a pig model of HS and reperfusion, administration of FX06 during reperfusion protects shock- susceptible organs such as heart, lung, liver, and small intestine.

This publication has 44 references indexed in Scilit: